SURVEILLANCE AND SYNTHETIC SUB-UNIT DNA VACCINES FOR PANDEMIC PREPAREDNESS AND RESPONSE​

SURVEILLANCE

Replikin Bioradar software’s surveillance identifies increases in the Replikins sequences in the genome up to two years before outbreaks.  The surveillance provides time for pre-outbreak public health measures to be implemented.

VACCINES

The company’s ReplivaxTM genomic DNA vaccine platform has the unique capacity to rapidly design and manufacture purely synthetic DNA peptide vaccines by solid phase synthesis which can be mass produced to meet world pandemic needs in weeks and can be adjusted in design to protect against mutated pathogens.

CONTACT US

Address:
Replikins, Ltd
38 the Fenway
Boston, MA 02215

Phone: (646) 320-5910
Fax: (617) 536-0657
Email: samuel.bogoch@replikins.com